Yes, pro apoptotic agents have therapeutic applications, particularly in cancer treatment. By selectively inducing apoptosis in cancer cells, these agents help reduce tumor size and slow disease progression. Drugs like BH3 mimetics are designed to mimic natural pro-apoptotic proteins, thereby promoting apoptosis in cells that evade normal regulatory mechanisms.